Multiple choice Response of non-small cell lung cancer to gefitinib is predicted by mutation in Abl oncogene Myc oncogene NF1 gene EGF receptor gene Reveal answer Fill a bubble to check yourself D Correct answer Explanation Approximately 10% of patients with non-small cell lung cancer respond to gefitinib, which is predicted by EGF receptor gene mutation.